Hasil Pencarian  ::  Simpan CSV :: Kembali

Abstrak :
[Resistensi obat antimalaria mendorong pengembangan obat antimalaria baru. Salah satu alternatif pengembangan obat antimalaria adalah mengombinasikan klorokuin dengan komponen lain, contohnya ekstrak akar pasak bumi (Eurycoma longifolia jack.). Berbagai penelitian in vitro maupun in vivo telah membuktikan potensi pasak bumi sebagai antimalaria. Penelitian ini bertujuan untuk mengetahui efek pemberian kombinasi ekstrak akar pasak bumi dan klorokuin secara injeksi subkutan pada mencit (Mus musculus) yang diinfeksi Plasmodium berghei. Perlakuan yang diberikan adalah pemberian ekstrak akar pasak bumi dengan dosis 10 mg/kgBB, 20 mg/kgBB, serta kombinasi ekstrak akar pasak bumi dengan dua dosis tersebut dan klorokuin. Berdasarkan Peters 4-days suppressive test, pertumbuhan parasitemia mencit yang diberikan kombinasi obat memiliki nilai yang mendekati kontrol positif (0,60%), yaitu 0,60% pada dosis kombinasi pasak bumi 10 mg/kgBB dan 0,50% pada dosis 20 mg/kgBB namun analisis statistik menunjukkan perbedaan tersebut tidak bermakna (p>0,05). Hasil penghitungan penghambatan pertumbuhan parasit menunjukkan kecenderungan yang sama. Penghambatan pertumbuhan parasit kontrol positif menunjukkan angka 97,9% sementara pemberian kombinasi obat menunjukkan angka 97,7% (dosis pasak bumi10 mg/kgBB) dan 98,2% (dosis pasak bumi 20 mg/kgBB). Hal ini menunjukkan bahwa tidak ada perbedaan bermakna antara efek pemberian kombinasi ekstrak akar pasak bumi dan klorokuin secara injeksi subkutan dibandingkan dengan terapi klorokuin saja;Antimalarial drug resisstance demand us to develop new antimalarial drug. One of the alternative is combining chloroquine with new compund, for example pasak bumi root extract (Eurycoma longifolia jack). Many studies have shown the potency of pasak bumi root extract as a antimalarial drug. This study is aim to investigate the effect of combination of pasak bumi root extract and chloroquine which is administrated by subcoutaneous injection to Plasmodium berghei-infected mice. Mice were given pasak bumi root extract only with 10 mg/kgBW and 20 mg/kgBW dose , also combination therapy of pasak bumi root extract on same dose and choloquine. Based on Peters 4-days suppressive test, parasite growth in mice with combination therapy was nearing the postive control value (0.60%), 0.60% for 10 mg/kgBW dose and 0.50% for 20 mg/kgBW dose. However, the statistic analysis showed the difference was not significant (p>0.05). Growth inhibition counting showed the same trend. Positive control growth inhibiton value is 97.9% meanwhile the combination therapy group has 97.7% for 10 mg/kgBW dose and 98.2% for 20 mg/kgBW dose. The study suggests that there were no significat difference between the effect of subcutaneously administrated combination of pasak bumi extract root-chloroquine and chloroquine only therapy., Antimalarial drug resisstance demand us to develop new antimalarial drug. One of the alternative is combining chloroquine with new compund, for example pasak bumi root extract (Eurycoma longifolia jack). Many studies have shown the potency of pasak bumi root extract as a antimalarial drug. This study is aim to investigate the effect of combination of pasak bumi root extract and chloroquine which is administrated by subcoutaneous injection to Plasmodium berghei-infected mice. Mice were given pasak bumi root extract only with 10 mg/kgBW and 20 mg/kgBW dose , also combination therapy of pasak bumi root extract on same dose and choloquine. Based on Peters 4-days suppressive test, parasite growth in mice with combination therapy was nearing the postive control value (0.60%), 0.60% for 10 mg/kgBW dose and 0.50% for 20 mg/kgBW dose. However, the statistic analysis showed the difference was not significant (p>0.05). Growth inhibition counting showed the same trend. Positive control growth inhibiton value is 97.9% meanwhile the combination therapy group has 97.7% for 10 mg/kgBW dose and 98.2% for 20 mg/kgBW dose. The study suggests that there were no significat difference between the effect of subcutaneously administrated combination of pasak bumi extract root-chloroquine and chloroquine only therapy.]

Abstrak :
[Resistensi yang terjadi pada beberapa obat antimalaria, seperti klorokuin, mendasari gencarnya dilakukan penelitian yang bertujuan untuk menemukan terapi antimalaria alternatif, salah satunya dengan memanfaatkan potensi herbal dari alam Indonesia. Ekstrak tanaman yang terbukti pada penelitian in-vivo memiliki efek antimalaria adalah akar pasak bumi (Eurycoma longifolia jack). Penelitian ini merupakan penelitian eksperimental in-vivo yang menguji ekstrak akar pasak bumi dengan dosis 60 mg/kgbb, 75 mg/kgbb, dan 90 mg/kgbb terhadap mencit (Mus musculus) yang terinfeksi Plasmodium berghei. Peningkatan densitas parasitemia pada hari ke-4 terapi dosis 60 mg/kgbb lebih tinggi dari kontrol negatif, sedangkan terapi dosis 75 mg/kgbb dan 90 mg/kgbb lebih rendah dari kontrol negatif namun perbedaannya tidak signifikan secara statistik. Ditinjau dari persentase inhibisi parasitemia, terapi dosis 60 mg/kgbb memiliki persentase inhibisi parasitemia negatif, sedangkan terapi dosis 75 mg/kgbb dan 90 mg/kgbb memiliki persentase inhibisi parasitemia < 50%. Ditinjau dari kadar hemoglobin, ketiga dosis perlakuan memiliki kadar hemoglobin yang fluktuatif dan cenderung menurun hingga pada kondisi anemia. Hal ini menunjukkan bahwa ekstrak akar pasak bumi dosis 60 mg/kgbb tidak memiliki efek antimalaria, sedangkan dosis 75 mg/kgbb dan 90 mg/kgbb memiliki efek antimalaria namun kurang adekuat. Terapi dosis 90 mg/kgbb menunjukkan peningkatan densitas parasitemia hari ke-4 yang paling rendah dan persentase inhibisi parasitemia paling baik. Dengan demikian disimpulkan bahwa terapi ekstrak akar pasak bumi kurang tepat digunakan sebagai terapi tunggal malaria;Resistance on malaria medication, for example klorokuin, underlie the study that aim to find alternative malaria treatment by using herbal potention from the nature of Indonesia. Herbal extract that had been proven in vivo experimental study that has antimalarial effect is Pasak bumi root (Eurycoma longifolia jack). This study is in vivo experimental study that giving Pasak bumi root extract by dose 60 mg/kgbw, 75 mg/kgbw, and 90 mg/kgbw to mice (Mus musculus) infected by Plasmodium berghei. The increase of parasitemia density in the 4th day of treatment by dose 60 mg/kgbw is higher than negative control, while treatment by dose 75 mg/kgbw and 90 mg/kgbw are lower than negative control, but the difference is not significant in statistic analysis. Reviewed from parasitemia inhibition persentage, treatment by dose 60 mg/kgbw has negative parasitemia inhibition persentage, while treatment by dose 75 mg/kgbw and 90 mg/kgbw have parasitemia inhibition persentage <50%. Reviewed from hemoglobin level, those treatment by three doses have fluctuative hemoglobin level and tend to be decreasing till reaching anemia. It shows that pasak bumi root extract by dose 60 mg/kgbw does not have antimalarial effect, while 75 mg/kgbw and 90 mg/kgbw have inadequate antimalarial effect. Treatment by dose 90 mg/kgbw shows the lowest increase of 4th day parasitemia density and the best parasitemia inhibition persentage. Thus, it could be concluded that pasak bumi root extract is not good enough to be used as single treatment of malaria, Resistance on malaria medication, for example klorokuin, underlie the study that aim to find alternative malaria treatment by using herbal potention from the nature of Indonesia. Herbal extract that had been proven in vivo experimental study that has antimalarial effect is Pasak bumi root (Eurycoma longifolia jack). This study is in vivo experimental study that giving Pasak bumi root extract by dose 60 mg/kgbw, 75 mg/kgbw, and 90 mg/kgbw to mice (Mus musculus) infected by Plasmodium berghei. The increase of parasitemia density in the 4th day of treatment by dose 60 mg/kgbw is higher than negative control, while treatment by dose 75 mg/kgbw and 90 mg/kgbw are lower than negative control, but the difference is not significant in statistic analysis. Reviewed from parasitemia inhibition persentage, treatment by dose 60 mg/kgbw has negative parasitemia inhibition persentage, while treatment by dose 75 mg/kgbw and 90 mg/kgbw have parasitemia inhibition persentage <50%. Reviewed from hemoglobin level, those treatment by three doses have fluctuative hemoglobin level and tend to be decreasing till reaching anemia. It shows that pasak bumi root extract by dose 60 mg/kgbw does not have antimalarial effect, while 75 mg/kgbw and 90 mg/kgbw have inadequate antimalarial effect. Treatment by dose 90 mg/kgbw shows the lowest increase of 4th day parasitemia density and the best parasitemia inhibition persentage. Thus, it could be concluded that pasak bumi root extract is not good enough to be used as single treatment of malaria]

Abstrak :
ABSTRAK
Malaria merupakan penyakit infeksi dengan prevalensi yang tinggi di Indonesia. Peningkatan resistensi terhadap pengobatan malaria telah ditemukan di beberapa negara untuk mengindikasikan bahwa penelitian dan pengembangan antimalaria baru sangat dibutuhkan. Penelitian ini bertujuan untuk menemukan antimalaria alternatif, dengan memanfaatkan ekstrak tanaman herbal, yaitu Spirulina dan Pasak Bumi. Penelitian ini merupakan penelitian eksperimental yang menguji pemberian Spirulina secara tunggal dan kombinasi dengan ekstrak akar Pasak Bumi terhadap mencit Mus musculus yang terinfeksi Plasmodium berghei. Dosis Spirulina yang digunakan pada penelitian ini adalah 300 mg/kgBB dan 500 mg/kgBB sedangkan dosis ekstrak Pasak Bumi yang digunakan adalah 60 mg/kgBB dan 75 mg/kgBB. Pada semua kelompok perlakuan terjadi peningkatan tingkat parasitemia pada hari ke-4 dengan persentase inhibisi parasitemia yang negatif. Hal ini menunjukkan bahwa Spirulina dosis 300 mg/kgBB dan 500 mg/kgBB dan ekstrak akar pasak bumi dosis 60 mg/kgBB dan 75 mg/kgBB tidak memiliki efek antimalaria, Dengan demikian, dapat disimpulkan bahwa pemberian ekstrak Spirulina tunggal dan kombinasi Spirulina dengan ekstrak Pasak Bumi pada dosis di atas tidak efektif sebagai antimalaria.

---

ABSTRACT
Malaria is an infectious disease with high prevalence in Indonesia. Increasing in resistance to malaria therapy has been observed in several countries to indicate that new antimalarial studies and development are needed. This study is aimed to find alternative antimalaria by using herbal plant extracts, namely Spirulina and Pasak Bumi. This study is an experimental study that tested the Spirulina administration singly and in combination with the extract of Pasak Bumi root to the mice Mus musculus infected with Plasmodium berghei. The dosage of Spirulina used in this study was 300 mg kgBW and 500 mg kgBW while the dosage of Pasak Bumi root extract was 60 mg kgBW and 75 mg kgBW. In all treatment groups, there was an increased level of parasitemia on day 4 with negative parasitemia inhibition percentage. It shows that Spirulina dose of 300 mg kgBW and 500 mg kg BW and Pasak Bumi root extract by dose 60 mg kgBB and 75 mg kgBW have no antimalarial effect. Thus, it can be concluded that administration of Spirulina singly and the combination of Spirulina and Pasak Bumi root extract are not effective as antimalaria.